Highline Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Highline Wealth Partners's BMY Position: Q3 2026 in Review
Highline Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 29% in Q3 2026, buying an estimated $8.15K and bringing the position to 578 shares worth $36.1K. The position accounts for 0.01% of the portfolio, ranked #314.
Highline Wealth Partners first reported a position in BMY in Q3 2022 and has held it in 17 quarters since. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Highline Wealth Partners held 578 shares of Bristol-Myers Squibb worth $36.1K as of Q3 2026.
- Highline Wealth Partners bought 129 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.15K.
- Bristol-Myers Squibb made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #314 holding.
- Highline Wealth Partners first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 17 quarters since.
- 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.